Your browser doesn't support javascript.
loading
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study.
Opat, Stephen; Tedeschi, Alessandra; Hu, Bei; Linton, Kim M; McKay, Pamela; Leitch, Sophie; Coleman, Morton; Zinzani, Pier Luigi; Jin, Jie; Sun, Mingyuan; Sobieraj-Teague, Magdalena; Browett, Peter; Ke, Xiaoyan; Thieblemont, Catherine; Ardeshna, Kirit; Bijou, Fontanet; Walker, Patricia; Hawkes, Eliza A; Ho, Shir-Jing; Zhou, Keshu; Liang, Zhiyu; Xu, Jianfeng; Tankersley, Chris; Delarue, Richard; Co, Melannie; Trotman, Judith.
Afiliação
  • Opat S; Monash Health and Monash University, Clayton, VIC, Australia.
  • Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Hu B; Levine Cancer Institute/Atrium Health, Charlotte, NC.
  • Linton KM; Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester, United Kingdom.
  • McKay P; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • Leitch S; North Shore Hospital, Auckland, New Zealand.
  • Coleman M; Clinical Research Alliance, Lake Success, NY.
  • Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia "Seràgnoli," and Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy.
  • Jin J; The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China.
  • Sun M; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Sobieraj-Teague M; Flinders Medical Centre, Bedford Park, SA, Australia.
  • Browett P; Auckland City Hospital, Grafton, New Zealand.
  • Ke X; Peking University Third Hospital, Beijing, China.
  • Thieblemont C; Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncology, Paris University Diderot, Paris, France.
  • Ardeshna K; University College London Hospitals/University College London Biomedical Research Centre, London, UK.
  • Bijou F; Institut Bergonié, Bordeaux, France.
  • Walker P; Peninsula Private Hospital, Ramsay Health Care, Frankston, VIC, Australia.
  • Hawkes EA; Olivia Newton-John Cancer Research Centre, Austin Health, Heidelberg, VIC, Australia.
  • Ho SJ; St George Hospital, Kogarah, NSW, Australia.
  • Zhou K; Henan Cancer Hospital, Zhengzhou, China.
  • Liang Z; BeiGene, Shanghai, China.
  • Xu J; BeiGene, Ridgefield Park, NJ.
  • Tankersley C; BeiGene, San Mateo, CA.
  • Delarue R; BeiGene, Basel, Switzerland.
  • Co M; BeiGene, San Mateo, CA.
  • Trotman J; Concord Repatriation General Hospital and University of Sydney, Concord, NSW, Australia.
Blood Adv ; 7(22): 6801-6811, 2023 11 28.
Article em En | MEDLINE | ID: mdl-37682792
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B / Magnolia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B / Magnolia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article